April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Role of the Choroidal Blood Flow in the Elimination of Sodium Fluorescein (NaFl) Delivered by an Episcleral Implant
Author Affiliations & Notes
  • J. E. Chan
    Duke University School of Medicine, Durham, North Carolina
  • T. A. Pridgen
    Ophthalmology, Duke Universtiy Medical Center, Durham, North Carolina
  • K. G. Csaky
    Ophthalmology, Duke Universtiy Medical Center, Durham, North Carolina
  • Footnotes
    Commercial Relationships  J.E. Chan, None; T.A. Pridgen, None; K.G. Csaky, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5955. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. E. Chan, T. A. Pridgen, K. G. Csaky; Role of the Choroidal Blood Flow in the Elimination of Sodium Fluorescein (NaFl) Delivered by an Episcleral Implant. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5955.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Drug delivery via an episcleral implant is an attractive approach for the therapy of chronic diseases. However evidence to date suggests this approach allows for only limited drug penetration to the posterior segment due in part to rapid choroidal blood flow resulting in efficient elimination of drug. In this study, we sought to determine the extent of elimination by choroidal blood flow of hydrophilic drug delivery by an episcleral implant.

Methods: : Sprague-Dawley rats were injected with intravenous indocyanine green (ICG) and the large penetrating vessel surrounding the optic nerve in one eye was photocoagulated using a diode (810 nm) laser to achieve choroidal nonperfusion. Ablation of the choroidal vasculature was verified by the use of intravenous concanavalin A and examination of choroidal and retinal flatmounts. Following laser photocoagulation, implants containing 2% NaFl were placed episclerally in the superotemporal quadrant of both eyes. After various time points after complete dissolution of the implants, both eyes were enucleated and the retina and conjunctiva/choroid/sclera complex (CCSC) were dissected. A novel method of tissue dissolution, extraction and quantitation of NaFl from the various ocular tissues using a spectrophotometer was performed.

Results: : A standard curve of varying concentrations of NaFl in the corresponding eye tissues was generated and demonstrated linearity over a range of 4.7 ng/mL to 470 ng/mL while the efficiency of extraction was found to be >98%. The elimination curve of NaFl in untreated control eyes demonstrated a concentration of 25.3 ng of NaFl per mg of wet tissue weight in the CCSC at 3 hrs with a reduction of 93.9% of drug at 3 hrs (n=5) while only 0.65% of NaFl partitioned into the retina. Following ICG-directed choroidal occlusion, concanavalin A flatmounts demonstrated complete nonperfusion of >90% of the choroid and retina. The elimination curve of NaFl in laser-treated eyes demonstrated a concentration of 16.6 ng of NaFl per mg of wet tissue weight in the CCSC at 3 hrs with a reduction of 94.8% of drug at 3 hrs (n=2) while only 0.50% of NaFl partitioned into the retina.

Conclusions: : These findings show that selective ablation of the choroidal vasculature does not significantly alter episcleral elimination of drugs, suggesting that the choroidal vasculature is likely not the major elimination route for episclerally delivered drugs.

Keywords: choroid • laser • photodynamic therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×